Precision treatment for rare cancers using lab-grown tumor models
Treatments studied
Part of Cancer clinical trials.
This trial tests if growing a patient's tumor cells in the lab (organoids) and analyzing their genes can help doctors choose more effective treatments for rare cancers. You might be eligible if you have an advanced rare solid tumor and can provide fresh or stored tumor tissue for testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have an advanced or spreading rare solid tumor confirmed by biopsy.
- You need to be in fairly good health, able to care for yourself, and expected to live at least 3 months.
- You must have at least one tumor that can be measured on scans (like a CT or MRI) that hasn't been treated with radiation or has grown after radiation.
- You must be willing to provide tumor samples (either from a prior surgery, a fresh biopsy, or fluid from around a tumor) for lab testing.
- You must also provide a sample of stored tumor tissue (paraffin block or slides) and a blood sample for genetic testing.
- Any side effects from past treatments must have mostly gone away (except hair loss), and you must agree to use effective birth control during the trial and for 8 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests targeted drugs or immunotherapy based on the genetic features of your tumor. It may help people with rare, advanced cancers whose disease has progressed after standard treatment options.
This trial is designed for people with rare types of cancer. It tests new therapies and technologies, and aims to find which ones work best for different tumors. You will need to provide a fresh tumor sample and blood sample for testing.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
This trial tests whether using a personalized approach—growing your tumor cells in the lab to find the best treatment—can work better than standard treatments chosen by your doctor. It is for people with advanced breast cancer that has stopped responding to at least two previous treatments.
This trial looks at a more tailored way to choose treatment for people with rare cancers that have spread or grown locally and can’t be cured with standard therapies. The goal is to better target the tumor to improve the chance of tumor shrinkage or eradication.
This study collects evidence on personalized (“targeted”) cancer treatments for adults with rare cancers or rare tumor changes. If you may qualify, it may help make these treatments more widely available in the future by studying how well they work and how patients feel.
Hear when a new Rare Tumour trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.